Literature DB >> 27681418

mTORC1 Is a Major Regulatory Node in the FGF21 Signaling Network in Adipocytes.

Annabel Y Minard1, Shi-Xiong Tan2, Pengyi Yang3, Daniel J Fazakerley4, Westa Domanova4, Benjamin L Parker4, Sean J Humphrey4, Raja Jothi5, Jacqueline Stöckli4, David E James6.   

Abstract

FGF21 improves the metabolic profile of obese animals through its actions on adipocytes. To elucidate the signaling network responsible for mediating these effects, we quantified dynamic changes in the adipocyte phosphoproteome following acute exposure to FGF21. FGF21 regulated a network of 821 phosphosites on 542 proteins. A major FGF21-regulated signaling node was mTORC1/S6K. In contrast to insulin, FGF21 activated mTORC1 via MAPK rather than through the canonical PI3K/AKT pathway. Activation of mTORC1/S6K by FGF21 was surprising because this is thought to contribute to deleterious metabolic effects such as obesity and insulin resistance. Rather, mTORC1 mediated many of the beneficial actions of FGF21 in vitro, including UCP1 and FGF21 induction, increased adiponectin secretion, and enhanced glucose uptake without any adverse effects on insulin action. This study provides a global view of FGF21 signaling and suggests that mTORC1 may act to facilitate FGF21-mediated health benefits in vivo.
Copyright © 2016 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FGF21; UCP1; adipocyte; insulin resistance; mTOR; mTORC1; obesity; phosphoproteome; phosphoproteomics; signaling

Mesh:

Substances:

Year:  2016        PMID: 27681418      PMCID: PMC6485955          DOI: 10.1016/j.celrep.2016.08.086

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  39 in total

1.  Neuroprotective Effect of Lentivirus-Mediated FGF21 Gene Delivery in Experimental Alzheimer's Disease is Augmented when Concerted with Rapamycin.

Authors:  Violina Kakoty; Sarathlal K C; Chih-Hao Yang; Shobha Kumari; Sunil Kumar Dubey; Rajeev Taliyan
Journal:  Mol Neurobiol       Date:  2022-02-10       Impact factor: 5.590

Review 2.  Signaling pathways in obesity: mechanisms and therapeutic interventions.

Authors:  Xue Wen; Bohan Zhang; Beiyi Wu; Haitao Xiao; Zehua Li; Ruoyu Li; Xuewen Xu; Tao Li
Journal:  Signal Transduct Target Ther       Date:  2022-08-28

3.  Latexin deficiency attenuates adipocyte differentiation and protects mice against obesity and metabolic disorders induced by high-fat diet.

Authors:  Shuang Kan; Rong Li; Yanhui Tan; Fang Yang; Shaohua Xu; Lingzhu Wang; Lijun Zhang; Xuchen Sun; Xuanming Chen; Yuting Yang; Wei Shu; Huaibin Wan; Zheng-Feng Chen; Hong Liang; Ming Chen
Journal:  Cell Death Dis       Date:  2022-02-24       Impact factor: 9.685

Review 4.  The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic.

Authors:  Leiluo Geng; Karen S L Lam; Aimin Xu
Journal:  Nat Rev Endocrinol       Date:  2020-08-06       Impact factor: 43.330

Review 5.  FGF21 in obesity and cancer: New insights.

Authors:  Weiqin Lu; Xiaokun Li; Yongde Luo
Journal:  Cancer Lett       Date:  2020-11-29       Impact factor: 8.679

6.  Sex and genetic background define the metabolic, physiologic, and molecular response to protein restriction.

Authors:  Cara L Green; Heidi H Pak; Nicole E Richardson; Victoria Flores; Deyang Yu; Jay L Tomasiewicz; Sabrina N Dumas; Katherine Kredell; Jesse W Fan; Charlie Kirsh; Krittisak Chaiyakul; Michaela E Murphy; Reji Babygirija; Gregory A Barrett-Wilt; Joshua Rabinowitz; Irene M Ong; Cholsoon Jang; Judith Simcox; Dudley W Lamming
Journal:  Cell Metab       Date:  2022-02-01       Impact factor: 27.287

7.  Dnmt3a is an epigenetic mediator of adipose insulin resistance.

Authors:  Dongjoo You; Emma Nilsson; Danielle E Tenen; Anna Lyubetskaya; James C Lo; Rencong Jiang; Jasmine Deng; Brian A Dawes; Allan Vaag; Charlotte Ling; Evan D Rosen; Sona Kang
Journal:  Elife       Date:  2017-11-01       Impact factor: 8.140

8.  Repletion of branched chain amino acids reverses mTORC1 signaling but not improved metabolism during dietary protein dilution.

Authors:  Adriano Maida; Jessica S K Chan; Kim A Sjøberg; Annika Zota; Dieter Schmoll; Bente Kiens; Stephan Herzig; Adam J Rose
Journal:  Mol Metab       Date:  2017-06-24       Impact factor: 7.422

9.  FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.

Authors:  Emilio P Mottillo; Eric M Desjardins; Andreas M Fritzen; Vito Z Zou; Justin D Crane; Julian M Yabut; Bente Kiens; Derek M Erion; Adhiraj Lanba; James G Granneman; Saswata Talukdar; Gregory R Steinberg
Journal:  Mol Metab       Date:  2017-04-05       Impact factor: 7.422

10.  Fructose Protects Against Acetaminophen-Induced Hepatotoxicity Mainly by Activating the Carbohydrate-Response Element-Binding Protein α-Fibroblast Growth Factor 21 Axis in Mice.

Authors:  Deqiang Zhang; Sujuan Wang; Erin Ospina; Omar Shabandri; Daniel Lank; Jephte Y Akakpo; Zifeng Zhao; Meichan Yang; Jun Wu; Hartmut Jaeschke; Pradip Saha; Xin Tong; Lei Yin
Journal:  Hepatol Commun       Date:  2021-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.